Skip to main content
. 2016 Nov 5;17:153. doi: 10.1186/s12875-016-0548-2

Table 4.

Characteristics of patient study population attending intervention and control practices at baseline

Characteristic/Category Intervention (n = 34) Control (n = 47)
n (%) Mean (SD) n (%) Mean (SD)
Male 20 (58.8 %) 30 (63.8 %)
Age 41.5 (7.9) 42.4 (8.8)
Ever injected drugs 23 (67.6 %) 38 (80.9 %)
Age of first injection 21.3 (3.4) 21.8(6.3)
Hepatitis C positive 20 (58.8 %) 29 (61.7 %)
Receiving methadone 33 (97.1 %) 47 (100 %)
Age first methadone use 25.6 (8.3) 25.8 (7.9)
Mean methadone dose 82.2 (22.7) 65.2 (28.6)
Attends Level 1 GP 15 (44.1 %) 26 (55.3 %)
Attends Level 2 GP 19 (55.9 %) 21 (44.7 %)
Geographical area of GP:
 East 30 (88.2 %) 43 (91.5 %)
 West 4 (11.8 %) 4 (8.5 %)
Employed 6 (17.6 %) 2 (4.3 %)
Current accommodation:
 Rented 9 (26.5 %) 16 (34 %)
 Owned 4 (11.8 %) 4 (8.5 %)
 Family of origin 3 (8.8 %) 8 (17 %)
 Social housing 15 (44.1 %) 17 (36.2 %)
 Supported housing 2 (5.9 %) 2 (4.3 %)
 No Fixed abode 1 (2.9 %) 0 (0 %)
Past 30-day drug use (self-reported)a
Number of patients who used illicit drugs in the last 30 daysb 14 (41.2 %) 17 (36.2 %)
Alcohol screening*
Q: Have you ever been asked about your alcohol use by healthcare professionals?
19 (55.9 %) 31 (66 %)
Alcohol brief intervention**
Q: Did they advise you on safe drinking or talk to you about alcohol?
14 (41.2 %) 23 (48.9 %)
Specialist referral***
Q: Have you ever been referred to a specialist/ addiction counsellor for alcohol use?
7 (20.6 %) 7 (14.9 %)

aData obtained from baseline patient questionnaires with data referring to the previous 30 days

bHeroin, illicit methadone, illicit benzodiazepines, cocaine, amphetamines, cannabis, other drugs

* ICC (SE) = 0.016 (0.014)

** ICC (SE) = –0.06 (0.017)

*** ICC (SE) = 0.22 (0.026)